Literature DB >> 22605822

Use of decompression tubes in the management of excessively large odontogenic keratocyst.

Janardan B Garde1, Adwait Uday Kulkarni, Dattaprasad P Dadhe, Vikramsinh B Deshmukh.   

Abstract

Odontogenic keratocyst (OKC) is a unique cyst because of its locally aggressive behaviour, high recurrence rate and characteristic histological appearance. A radical surgical approach is commonly advocated with morbid and disfiguring results. This approach also presents several reconstructive obstacles especially in anterior mandible. In this case report the authors present a 25-year-old male patient with a large OKC and treatment with decompression followed by enucleation, and chemical cauterisation. This approach though demanding prolonged treatment time and postoperative follow-up decreases the morbidity to a great extent in a young individual. At the same time, it allows an opportunity for the maxillofacial surgeon to preserve the natural dentition, maintain function and safeguard cosmesis. In our case, the authors effectively achieved all the aforementioned objectives. At the same time a radical option of treatment is still left in the armoury if required at a later date.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605822      PMCID: PMC3343726          DOI: 10.1136/bcr.12.2011.5318

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Surgical treatment algorithm for odontogenic keratocyst: combined treatment of odontogenic keratocyst and mandibular defect with marsupialization, enucleation, iliac crest bone graft, and dental implants.

Authors:  Len Tolstunov; Trevor Treasure
Journal:  J Oral Maxillofac Surg       Date:  2008-05       Impact factor: 1.895

2.  The implications of inflammation in odontogenic keratocysts.

Authors:  B Rodu; A L Tate; M G Martinez
Journal:  J Oral Pathol       Date:  1987-11

3.  Marsupialization inhibits interleukin-1alpha expression and epithelial cell proliferation in odontogenic keratocysts.

Authors:  Tomohiro Ninomiya; Yasutaka Kubota; Takehiko Koji; Kanemitsu Shirasuna
Journal:  J Oral Pathol Med       Date:  2002-10       Impact factor: 4.253

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.